@article{43c362a3bb4545c8976fcd9ed2424cb2,
title = "Correction to: Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies (The Journal of Clinical Endocrinology and Metabolism (2021) 106:11 (e4666-e4679) DOI: 10.1210/clinem/dgab438)",
abstract = "Table 2 contained an error in the listed dose. For cohort B, the dose was incorrectly listed as 200 mg QD. The correct dose is 200 mg BID.",
author = "K. Sarafoglou and Barnes, {C. N.} and M. Huang and Imel, {E. A.} and I. Madu and Merke, {D. P.} and D. Moriarty and S. Nakhle and Newfield, {R. S.} and Vogiatzi, {M. G.} and Auchus, {R. J.}",
note = "Publisher Copyright: {\textcopyright} 2022 Endocrine Society. All rights reserved.",
year = "2022",
month = aug,
day = "1",
doi = "10.1210/clinem/dgac224",
language = "English (US)",
volume = "107",
pages = "E3546",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",
}